These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 3111134)

  • 21. The relationship between Neisseria meningitidis of serogroups Z1 and 29E.
    Fallon RJ
    J Med Microbiol; 1976 May; 9(2):239-42. PubMed ID: 58994
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Cross reactions between Staphylococcus aureus and Neisseria meningitidis].
    Vaneeva NP; Efremova VN; Shagam NL; Iastrebova NE; Kaverina KG
    Zh Mikrobiol Epidemiol Immunobiol; 1988 Jan; (1):58-61. PubMed ID: 2452532
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Immunochemical study of the meningococcal cell wall].
    Belova TN; Markova AI; Kushnarev VM; Zvenigorodskaia VP; Rostovtseva NA
    Zh Mikrobiol Epidemiol Immunobiol; 1976 Nov; (11):110-4. PubMed ID: 827164
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Outer membrane antigens of Neisseria meningitidis group B serotype 2 studied by crossed immunoelectrophoresis.
    Hoff GE; Frasch CE
    Infect Immun; 1979 Sep; 25(3):849-56. PubMed ID: 115791
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Immunologic properties of purified and complex preparations of group-B meningococcal polysaccharide].
    Alliluev AP; Kotel'nikova OV; Kuvakina VA; Basnak'ian IA; Valerius II
    Zh Mikrobiol Epidemiol Immunobiol; 1986 Sep; (9):7-12. PubMed ID: 3098007
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunologic hyporesponsiveness in man to group C meningococcal polysaccharide.
    Artenstein MS; Brandt BL
    J Immunol; 1975 Jul; 115(1):5-7. PubMed ID: 807629
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cross-protective antigens of Neisseria meningitidis obtained from Slaterus group Y.
    Jennings HJ; Martin A; Kenny CP; Diena BB
    Infect Immun; 1972 Apr; 5(4):547-51. PubMed ID: 4629126
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Physicochemical properties of Neisseria meningitidis group X polysaccharide antigen.
    Apicella MA; Robinson JA
    Infect Immun; 1972 Nov; 6(5):773-8. PubMed ID: 4629206
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The capsular polysaccharide of serogroup-B meningococci: its immunobiological properties].
    Del'vig AA; Semenov BF
    Zh Mikrobiol Epidemiol Immunobiol; 1999; (5):52-6. PubMed ID: 10852023
    [No Abstract]   [Full Text] [Related]  

  • 30. Characteristics of two types of meningococcal group C polysaccharide conjugates using tetanus toxoid as carrier protein.
    Beuvery EC; Roy R; Kanhai V; Jennings HJ
    Dev Biol Stand; 1986; 65():197-204. PubMed ID: 3104115
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A quantitative ELISA for antigen-specific IgG subclasses using equivalence dilutions of anti-kappa and anti-subclass specific secondary reagents. Application to the study of the murine immune response against the capsular polysaccharide of Neisseria meningitidis serogroup B.
    Colino J; Diez M; Outschoorn I
    J Immunol Methods; 1996 Apr; 190(2):221-34. PubMed ID: 8621957
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [High-molecular antigenic complex of the pneumococcus: its properties].
    Rodionychev EA; Krasnoproshina LI; Padiukov LN; Tsvetkova NV
    Zh Mikrobiol Epidemiol Immunobiol; 1985 Mar; (3):23-8. PubMed ID: 3993288
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Intragroup serotyping of meningococci].
    Demina AA; Gorshkova VI
    Zh Mikrobiol Epidemiol Immunobiol; 1980 Sep; (9):43-9. PubMed ID: 6778039
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The phenotypic heterogeneity of meningococcal strains by their serogroup trait].
    Babich EM
    Mikrobiol Z; 1996; 58(1):65-72. PubMed ID: 8729467
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effectiveness of a mass immunization campaign against serogroup C meningococcal disease in Quebec.
    De Wals P; De Serres G; Niyonsenga T
    JAMA; 2001 Jan; 285(2):177-81. PubMed ID: 11176810
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Synthesis of group-specific polysaccharide by different strains of Neisseria meningitidis serogroup B under various conditions].
    Sivtseva LD; Levina LA
    Zh Mikrobiol Epidemiol Immunobiol; 1988 Jan; (1):11-5. PubMed ID: 3129885
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dot-immunobinding assay with a monoclonal antibody for detection of group B meningococcal antigen.
    Coll P; Borche L; Ausina V; Mirelis B; Prats G
    Eur J Clin Microbiol; 1986 Feb; 5(1):44-6. PubMed ID: 3084244
    [No Abstract]   [Full Text] [Related]  

  • 38. Protective efficacy of mouse serum to the N-propionyl derivative of meningococcal group B polysaccharide.
    Ashton FE; Ryan JA; Michon F; Jennings HJ
    Microb Pathog; 1989 Jun; 6(6):455-8. PubMed ID: 2505013
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Class-specific human bactericidal antibodies to capsular and noncapsular surface antigens of Neisseria meningitidis.
    Skevakis L; Frasch CE; Zahradnik JM; Dolin R
    J Infect Dis; 1984 Mar; 149(3):387-96. PubMed ID: 6425422
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Induction of immunologic memory by conjugated vs plain meningococcal C polysaccharide vaccine in toddlers: a randomized controlled trial.
    MacDonald NE; Halperin SA; Law BJ; Forrest B; Danzig LE; Granoff DM
    JAMA; 1998 Nov; 280(19):1685-9. PubMed ID: 9832000
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.